|
|
|
|
Biopharma Group
|
|
Quality By Design
|
|
Quality by Design (QbD) is a systematic approach to development that begins with the defined objectives and emphasizes science and quality risk management in order to achieve those goals. QbD ensures that the quality of the product is built into production processes from the outset, rather than being tested after development has already commenced.
|
|
|
|
|
|
|
 |
News and Press Releases |
 |
Coriolis Pharma and U-Medico Announce a Strategic Alliance
MARTINSRIED, Germany and OSAKA, Japan, March 17, 2022 / B3C newswire /
-- Coriolis Pharma, a globally operating service provider and one of
the world leaders in formulation research and development of
(bio)pharmaceutical drugs located in Germany, and U-Medico, an
innovative formulation development and biophysical characterisations
service provider located in Japan, today announce a strategic alliance
that includes an equity investment by Coriolis Pharma into U-Medico.
More info >> |
|
 |
White Papers |
 |
|
Pandemic respiratory vaccine clinical trials: a departure from business as usual
ICON plc
Around the world, the “V” words are on everyone’s lips: Virus and Vaccines. In response to the urgent need for a vaccine for COVID-19, researchers are, at time of publication, running 500+ clinical trials (and counting) on a number of antivirals, antibodies and vaccines. Promising possibilities range from novel new drugs/vaccines, repurposing treatments currently indicated for HIV, Ebola and malaria, to monoclonal antibodies and immune serum.
More info >> |
|
|
|
